Your browser doesn't support javascript.
loading
Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro.
Wang, Qi; Zi, Cheng-Ting; Wang, Jing; Wang, Yu-Na; Huang, Ye-Wei; Fu, Xue-Qi; Wang, Xuan-Jun; Sheng, Jun.
Afiliación
  • Wang Q; Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, China.
  • Zi CT; Tea Research Center of Yunnan, Kunming, China.
  • Wang J; College of Tea Science, Yunnan Agricultural University, Kunming, China.
  • Wang YN; Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, China.
  • Huang YW; Tea Research Center of Yunnan, Kunming, China.
  • Fu XQ; College of Tea Science, Yunnan Agricultural University, Kunming, China.
  • Wang XJ; Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, China.
  • Sheng J; Tea Research Center of Yunnan, Kunming, China.
Front Pharmacol ; 8: 966, 2017.
Article en En | MEDLINE | ID: mdl-29379436
ABSTRACT

Background:

Dendrobium officinale, a traditional Chinese medical herb with high value that is widely used in Asia, possesses many positive effects on human health, including anti-chronic inflammation, anti-obesity, and immune modulation properties; however, whether D. officinale has inhibitory effects on postmenopausal osteoporosis remains unknown.

Objective:

We investigated the effects of D. officinale extract (DOE) on ovariectomy-induced bone loss in vivo and on osteoclastogenesis in vitro.

Methods:

In vivo, female rats were divided into a sham-operated (sham) group and five ovariectomized (OVX) subgroups OVX with vehicle (OVX), OVX with Xian-Ling-Gu-Bao capsule (240 mg/kg body weight/day), and OVX with low-, medium-, and high-dose DOE (150, 300, and 600 mg/kg body weight/day, respectively). Animals in each group were administered their corresponding treatments for 13 weeks. Body weight, serum biochemical parameters, uterine and femoral physical parameters, bone mineral density (BMD), bone biomechanical properties, and bone microarchitecture were obtained. In vitro, the effects of DOE on osteoclastogenesis were examined using RAW264.7 cells. The effects of DOE on osteoclastogenesis and the expression of osteoclast-specific marker genes and proteins were determined.

Results:

DOE effectively ameliorated serum biochemical parameters, especially alleviated estradiol (E2) deficiency and maintained calcium and phosphorus homeostasis. DOE improved uterine and femoral physical parameters. In addition, DOE improved femoral BMD and biomechanical properties. DOE significantly ameliorated bone microarchitecture. Moreover, DOE inhibited osteoclastogenesis independent of its cytoxicity and suppressed the expression of osteoclast-specific marker genes and proteins.

Conclusion:

DOE can effectively prevent ovariectomy-induced bone loss in vivo and inhibit osteoclastogenesis in vitro.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: China
...